109 related articles for article (PubMed ID: 20665369)
21. Efficacy of Rhizophora mangle aqueous bark extract (RMABE) in the treatment of aphthous ulcers: a pilot study.
de Armas E; Sarracent Y; Marrero E; Fernández O; Branford-White C
Curr Med Res Opin; 2005 Nov; 21(11):1711-5. PubMed ID: 16307690
[TBL] [Abstract][Full Text] [Related]
22. Medicinal plants used by the people of Northeast India for curing malaria.
Bora U; Sahu A; Saikia AP; Ryakala VK; Goswami P
Phytother Res; 2007 Aug; 21(8):800-4. PubMed ID: 17533627
[TBL] [Abstract][Full Text] [Related]
23. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.
Farré M; Roset PN; Llorente M; Márquez M; Albet C; Pérez JA; Herrero E; Ortíz JA
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):343-50. PubMed ID: 9379783
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
[TBL] [Abstract][Full Text] [Related]
27. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
29. Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.
Kim BH; Yi S; Kim J; Lim KS; Kim KP; Lee B; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Jun; 31(6):1234-43. PubMed ID: 19695390
[TBL] [Abstract][Full Text] [Related]
30. A double-blind clinical safety study of noni fruit juice.
West BJ; White LD; Jensen CJ; Palu AK
Pac Health Dialog; 2009 Nov; 15(2):21-32. PubMed ID: 20443518
[TBL] [Abstract][Full Text] [Related]
31. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis.
Hubbert M; Sievers H; Lehnfeld R; Kehrl W
Eur J Med Res; 2006 Jan; 11(1):20-6. PubMed ID: 16504956
[TBL] [Abstract][Full Text] [Related]
33. Antimalarial activities of Tithonia diversifolia (Asteraceae) and Crossopteryx febrifuga (Rubiaceae) on mice in vivo.
Elufioye TO; Agbedahunsi JM
J Ethnopharmacol; 2004 Aug; 93(2-3):167-71. PubMed ID: 15234749
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
35. In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri.
Tona L; Mesia K; Ngimbi NP; Chrimwami B; Okond'ahoka ; Cimanga K; de Bruyne T; Apers S; Hermans N; Totte J; Pieters L; Vlietinck AJ
Ann Trop Med Parasitol; 2001 Jan; 95(1):47-57. PubMed ID: 11235553
[TBL] [Abstract][Full Text] [Related]
36. Acute and sub-acute toxicity of ethanolic extract of Canthium mannii Hiern stem bark on Mus musculus.
Poné JW; Mbida M; Bilong CF
Indian J Exp Biol; 2011 Feb; 49(2):146-50. PubMed ID: 21428217
[TBL] [Abstract][Full Text] [Related]
37. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice.
Muregi FW; Ishih A; Suzuki T; Kino H; Amano T; Mkoji GM; Miyase T; Terada M
Phytother Res; 2007 Apr; 21(4):337-43. PubMed ID: 17221829
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults.
Nell H; Siebert M; Chellan P; Gericke N
J Altern Complement Med; 2013 Nov; 19(11):898-904. PubMed ID: 23441963
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: a Phase I-II, open-label trial.
Vollmer T; Henney HR
Clin Ther; 2009 Oct; 31(10):2206-14. PubMed ID: 19922891
[TBL] [Abstract][Full Text] [Related]
40. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
